Business Day

ICPS offers a win-win for arthroplas­ty

• Better, more affordable care in hip and knee surgery

- /Supplied

There are numerous complex reasons for the private healthcare sector struggling to deliver affordable and quality healthcare to patients, says Grant Rex, CEO at Improved Clinical Pathway Services (ICPS).

One of the reasons is that healthcare practition­ers practise in a relatively isolated way, often without the benefit of a multidisci­plinary team approach or reference to evidence-based best practice, says Rex.

Healthcare practition­ers furthermor­e charge for their services on a fee-for-service basis, with no agreed guideline about what to charge for and how much to charge.

“Medical schemes are concerned with limiting their exposure to the risk of healthcare practition­ers charging on a feefor-service basis with no reference to what is cost effective nor to what services produce the best clinical outcomes.

“Simply reimbursin­g for any service on a fee-for-service basis will not result in the longevity of schemes as the risk that they insure is proving to be unwieldy and expensive.”

Rex says ICPS has developed an innovative programme that improves the affordabil­ity and quality of healthcare.

“We provide clinical decision support to a network of healthcare practition­ers in private practice who enter into a service-level agreement with ICPS and perform hip and knee arthroplas­ty on patients for a fixed fee, using standardis­ed evidence-based guidelines as a clinical reference.

“Hospitals are contracted on a discounted fee-for-service basis, and prosthesis suppliers are contracted on the basis of a negotiated fee per system.

“The quality of the care provided in these arthroplas­ty cases is retrospect­ively assessed, and feedback [is] provided to the network clinicians for continued improvemen­t in care. As a result, there are better clinical outcomes for patients, fees are affordable for the schemes and the patients they insure, as well as being fair to the healthcare practition­er,” Rex says.

ICPS provides clinical decision support to network clinicians by means of standardis­ed clinical pathways, clinical outcome measuremen­ts and feedback to the network clinicians, which together deliver continuous quality improvemen­t of patient care.

Rex says ICPS facilitate­s access to hip and knee arthroplas­ty for medical schemes’ qualifying members.

For medical schemes whose benefit options ordinarily exclude arthroplas­ty, ICPS facilitate­s improved access to arthroplas­ty by making it possible for these medical schemes to offer this treatment to qualifying members.

For medical schemes whose benefit options ordinarily Healthcare practition­ers often practise without a multidisci­plinary approach or reference to evidence-based best practice, says Grant Rex, CEO at Improved Clinical Pathway Services.

include arthroplas­ty, ICPS provides an alternativ­e, alongside the convention­al fee-for-service arthroplas­ty option, facilitati­ng access to arthroplas­ty by either reducing the need for, or amount of, copayments.

The overall cost of arthroplas­ty to the medical scheme is

reduced and the clinical outcomes are improved.

Rex says a “patient is assessed pre-operativel­y by the treating surgeon, anaestheti­st and physiother­apist, in relation to evidence-based orthopaedi­c, medical, and anaestheti­c aspects of their state of health”.

ICPS has 70 teams, delivering arthroplas­ties in all nine provinces.

ICPS initially entered into contracts with the Transmed and Medihelp medical schemes, which led to 762 cases being taken out of the overburden­ed state sector. Waiting times for arthroplas­ty in the state sector are very long, examples being an average of eight years at Chris Hani Baragwanat­h Hospital, and an average of four years at Albert Luthuli Hospital.

“Clinical outcomes measured in more than 2,000 cases under the ICPS programme show enhanced patient recovery, as evidenced by reduced hospital stay from 6.9 days on average to 3.2 days.

“This shorter hospital stay reduces the risk of postoperat­ive infections, and reduced high-care utilisatio­n results in decreased incidences of deepvein thrombosis and pulmonary embolism,” Rex says.

“The available data shows a reduced acute complicati­on rate which is also evident from the 90-day readmissio­n rates, which have declined on average from 12% to 4.5%,” says Rex.

He notes that ICPS achieves an average cost saving of between R20,000 and R30,000 per arthroplas­ty case, which benefits medical schemes as hip and knee arthroplas­ty combined are their biggest single cost item and amount to a spend of nearly R2bn per annum.

A 20% saving implies a R400m saving a year for the industry, which could result in lower premiums to members, or at least help limit annual premium increases to around the percentage increase in the consumer price index.

“Our group has performed several thousand major joint replacemen­ts with clinical complicati­ons at 50% of the national average and costs 10% to 30% less than the average excluding the savings from lower complicati­ons,” says Rex.

 ??  ?? Alternativ­e:
Alternativ­e:

Newspapers in English

Newspapers from South Africa